Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans

Journal of Functional Foods

Volumn 3, Issue 1, 2011, Pages 17-24

  Schneider, Inga ^a   Kressel, Gaby ^a   Meyer, Annette ^a   Krings, Ulrich ^a   Berger, Ralf G ^a   Hahn, Andreas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Atherogenic lipid profile; Human; Hyperlipidemia; Intervention study; Pleurotus ostreatus

Indexed keywords

ANIMALIA; LYCOPERSICON ESCULENTUM; PLEUROTUS OSTREATUS;

EID: 79953053000     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2010.11.004     Document Type: Article

References (44)

1. Alarcon J., Aguila S. Lovastatin production by Pleurotus ostreatus: effects of the C:N ratio. Zeitschrift für Naturforschung 2006, 61:95-98.
2. Alarcon J., Aguila S., Rancibia-Avila P., Fuentes O., Zamorano-Ponce E., Hernandez M. Production and purification of statins from Pleurotus ostreatus (basidiomycetes) strains. Zeitschrift für Naturforschung 2003, 58:62-64.
3. Andican G., Seven A., Uncu M., Cantasdemir M., Numan F., Burcak G. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease. Scandinavian Journal of Clinical and Laboratory Investigation 2008, 68:473-478.
4. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105:310-315.
5. Barter P.J., Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis 1996, 121:1-12.
6. Bobek P., Galbavy S. Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung 1999, 43:339-342.
7. Bobek P., Ginter E., Kuniak L., Babala J., Jurcovicova M., Ozdin L., et al. Effect of mushroom Pleurotus ostreatus and isolated fungal polysaccharide on serum and liver lipids in Syrian hamsters with hyperlipoproteinemia. Nutrition 1991, 7:105-108.
8. Bobek P., Ozdin L., Galbavy S. Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition 1998, 14:282-286.
9. Bobek P., Ozdin L., Kajaba I. Dose-dependent hypocholesterolaemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Physiological Research 1997, 46:327-329.
10. Boullier A., Bird D.A., Chang M.K., Dennis E.A., Friedman P., Gillotre-Taylor K., et al. Scavenger receptors, oxidized LDL, and atherosclerosis. Annals of the New York Academy of Sciences 2001, 947:214-222.
11. Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obesity Research 2000, 8:605-619.
12. Castelli W.P., Anderson K., Wilson P.W., Levy D. Lipids and risk of coronary heart disease. The Framingham study. Annals of Epidemiology 1992, 2:23-28.
13. Claessens M., van Baak M.A., Monsheimer S., Saris W.H. The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors. International Journal of Obesity 2009, 33:296-304.
14. Devaraj S., Mathur S., Basu A., Aung H.H., Vasu V.T., Meyers S., et al. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. Journal of the American College of Nutrition 2008, 27:267-273.
15. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids (macronutrients) 2005, DRI, The National Academy Press, Washington.
16. Diyabalanage T., Mulabagal V., Mills G., De Witt D.L., Nair M.G. Liperoxidation and cyclooxygenase enzyme inhibitory compounds from the lipophilic extracts of some culinary-medicinal higher basidiomycetes mushrooms. International Journal of Medicinal Mushrooms 2009, 11:375-382.
17. Enman J., Rova U., Berglund K.A. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). Journal of Agricultural and Food Chemistry 2007, 55:1177-1180.
18. Ginsberg H.N., Kris-Etherton P., Dennis B., Elmer P.J., Ershow A., Lefevre M., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA Study, protocol 1. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:441-449.
19. Gunde-Cimerman N., Cimerman A. Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase-lovastatin. Experimental Mycology 1995, 19:1-6.
20. Hennig B., Toborek M. Nutrition and endothelial cell function: Implications in atherosclerosis. Nutrition Research 2001, 21:279-293.
21. Higuchi M., Oshima S., Suzuki S. The effect of shi-i-take on the blood pressure and plasma cholesterol of spontaneously hypertensive rats. Japanese Journal of Nutrition 1978, 36:119-125.
22. Hossain S., Hashimoto M., Choudhury E.K., Alam N., Hussain S., Hasan M., et al. Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clinical and Experimental Pharmacology and Physiology 2003, 30:470-475.
23. Huang D., Ou B., Hampsch-Woodill M., Flanagan J.A., Deemer E.K. Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated beta-cyclodextrin as the solubility enhancer. Journal of Agricultural and Food Chemistry 2002, 50:1815-1821.
24. Illner A.K., Nöthlings U., Wagner K., Ward H., Boeing H. The assessment of individual usual food intake in large-scale prospective studies. Annals of Nutrition & Metabolism 2010, 56:99-105.
25. Keil U. Coronary artery disease: the role of lipids, hypertension and smoking. Basic Research in Cardiology 2000, 95(Suppl 1):I52-I58.
26. Kim M.Y., Seguin P., Ahn J.K., Kim J.J., Chun S.C., Kim E.H., et al. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. Journal of Agricultural and Food Chemistry 2008, 56:7265-7270.
27. Kurusawa S., Sugano T., Hayashi J. Studies on dietary fibre of mushrooms and edible wild plants. Nutrition Reports International 1982, 26:167-173.
28. Lamon-Fava S., Wilson P.W., Schaefer E.J. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1996, 16:1509-1515.
29. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition 2005, 81:230S-242S.
30. McBride P. Triglycerides and risk for coronary artery disease. Current Atherosclerosis Reports 2008, 10:386-390.
31. Opletal L., Jahodar L., Chobot V., Zdansky P., Lukes J., Bratova M., et al. Evidence for the anti-hyperlipidaemic activity of the edible fungus Pleurotus ostreatus. British Journal of Biomedical Science 1997, 54:240-243.
32. Rao A.V. Lycopene, tomatoes, and the prevention of coronary heart disease. Experimental Biology and Medicine 2002, 227:908-913.
33. Ripsin C.M., Keenan J.M., Jacobs D.R., Elmer P.J., Welch R.R., Van H.L., et al. Oat products and lipid lowering. A meta-analysis. Journal of the American Medical Association 1992, 267:3317-3325.
34. Salas-Salvado J., Bullo M., Perez-Heras A., Ros E. Dietary fibre, nuts and cardiovascular diseases. British Journal of Nutrition 2006, 96(Suppl 2):S46-S51.
35. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New English Journal of Medicine 1995, 333:1301-1307.
36. Souci S.W., Fachmann W., Kraut H. Food composition and nutrition tables. Die zusammensetzung der lebensmittel, nährwert-tabellen. La composition des aliments, tableux des valeurs nutritives 2008, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
37. Sun M., Xiao J., Zhang S. Therapeutic effect of some foods on hyperlipidemia in man. Acta Nutrition Sinica 1984, 6:127-133.
38. Suzuki S., Oshima S. Influence of shii-take (Lentinus edodes) on serum cholesterol. Mushroom Science 1976, 9:463-467.
39. Tenkanen L., Pietila K., Manninen V., Manttari M. The triglyceride issue revisited. Findings from the Helsinki Heart Study. Archives of Internal Medicine 1994, 154:2714-2720.
40. Nutrition, Metabolism and Cardiovascular Diseases 1998, 8:205-271. The International Task Force for Prevention of Coronary Heart Disease.
41. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. (2002). Circulation, 106, 3143-3421.
42. Tidke G., Rai M. Biotechnological potential of mushrooms: drugs and dye production. International Journal of Medicinal Mushrooms 2006, 8:351-360.
43. WHO technical report series. Diet, Nutrition and the Prevention of Chronic Disease 2003, 1:1. WHO.
44. Visioli F., Poli A., Richard D., Paoletti R. Modulation of inflammation by nutritional interventions. Current Atherosclerosis Reports 2008, 10:451-453.